Kypha's Corporate Minority Round

Kypha raised a round of funding on August 08, 2013. Investors include Sigma-Aldrich.

Kypha seeks to discover, develop and commercialize innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. The company's plan is for these tests to become standard…

Articles about Kypha's Corporate Minority Round: